株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

バイオマーカーの世界市場規模調査

Global Biomarker Market Size study, by Disease Indication, by Application, by End-Use, by Product Type and Regional Forecasts 2018-2025

発行 Bizwit Research & Consulting LLP 商品コード 799106
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
バイオマーカーの世界市場規模調査 Global Biomarker Market Size study, by Disease Indication, by Application, by End-Use, by Product Type and Regional Forecasts 2018-2025
出版日: 2019年02月13日 ページ情報: 英文
概要

当レポートでは、バイオマーカー(生体指標物質)の世界市場に注目し、今後の取引規模を疾患兆候、用途、利用者、製品形式、地域に分けて試算するほか、その背景を成す規制環境や技術開発、需給、競合動向などを分析しながら、同市場の将来展開を予測しています。

第1章 エグゼクティブサマリー

  • 市場寸見
  • 重要動向
  • 市場規模の試算と予測 - 世界全体およびセグメント別
    • バイオマーカー市場 - 疾患兆候別
    • バイオマーカー市場 - 用途別
    • バイオマーカー市場 - 利用者別
    • バイオマーカー市場 - 製品形式
    • バイオマーカー市場 - 地域別
  • 試算方法
  • 調査の前提

第2章 バイオマーカー市場の定義と範囲

  • 調査の目的
  • 市場の定義と範囲
    • 産業発展史
    • 調査の範囲
  • 予測対象年次
  • 通貨換算レート

第3章 バイオマーカーの市場動態

  • シーソー分析
    • 市場推進要因
    • 市場課題
    • 市場発展機会

第4章 バイオマーカー市場の産業分析

  • Porterのファイブフォースモデル
    • 買い手の交渉力
    • 売り手の交渉力
    • 新規参入者の脅威
    • 代替品の脅威
    • 競合
    • 将来に向けてのPorterファイべフォースモデル活用法
  • PEST分析
    • 政治環境
    • 経済環境
    • 社会環境
    • 技術環境
  • バリューチェーン分析
    • サプライヤー
    • メーカー/サービスプロバイダー
    • ディストリビューター
    • エンドユーザー
  • 買い手の主要選定基準
  • 規制の枠組み
  • 原価構成分析
    • 原材料費
    • 製造費
    • 人件費
  • 投資に比しての導入状況
  • アナリストの提言と結論

第5章 バイオマーカー市場 - 疾患兆候別

  • 市場寸見
  • 市場成績 - 有望モデル
  • 主要参入企業
  • バイオマーカー市場 - 項目別分析
    • がん
    • 心疾患
    • 感染性疾患
    • 神経疾患
    • 免疫疾患
    • その他

第6章 バイオマーカー市場 - 用途別

  • 市場寸見
  • 市場成績 - 有望モデル
  • 主要参入企業
  • バイオマーカー市場 - 項目別分析
    • 診断
    • 創薬・薬剤開発
    • その他

第7章 バイオマーカー市場 - 利用者別

  • 市場寸見
  • 市場成績 - 有望モデル
  • 主要参入企業
  • バイオマーカー市場 - 項目別分析
    • 病院
    • 研究施設
    • 救急外科センター
    • 診断試験施設

第8章 バイオマーカー市場 - 製品形式

  • 市場寸見
  • 市場成績 - 有望モデル
  • 主要参入企業
  • バイオマーカー市場 - 項目別分析
    • バイオマーカー試験キット
    • バイオマーカー分析装置

第9章 バイオマーカー市場 - 地域別分析

  • バイオマーカー市場 - 地域市場寸見
  • 北米のバイオマーカー市場寸見
    • 米国
    • カナダ
  • 欧州のバイオマーカー市場寸見
    • 英国
    • ドイツ
    • フランス
    • その他欧州
  • アジアのバイオマーカー市場寸見
    • 中国
    • インド
    • 日本
    • その他アジア太平洋州
  • ラテンアメリカのバイオマーカー市場寸見
    • ブラジル
    • メキシコ
  • その他の地域
    • 南米
    • 中東・アフリカ

第10章 競合情報

  • 企業別市場シェア
  • 有力市場施策
  • 企業プロファイル
    • Abbott Laboratories
    • Medtronic
    • BG Medicine Inc.
    • Hoffmann LA Roche Ltd.
    • Siemens Healthnineers
    • Nexus-DX
    • Qiagen N.V.
    • Lifesign LLC

第11章 調査方法

  • 調査方法
    • データマイニング
    • 分析
    • 市場規模の試算
    • 検証
    • 出版
    • 調査の前提
図表

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF BIOMARKER MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF BIOMARKER MARKET
  • TABLE 3. BIOMARKER MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. BIOMARKER MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
  • TABLE 7. BIOMARKER MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
  • TABLE 8. BIOMARKER MARKET ESTIMATES & FORECASTS BY Disease Indication 2015-2025 (USD BILLION)
  • TABLE 9. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 10. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 11. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 12. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 13. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 14. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 15. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 16. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 17. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 18. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 19. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 20. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 21. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 22. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 23. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 24. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 25. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 26. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 27. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 28. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 29. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 30. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 31. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 32. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 33. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 34. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 35. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 36. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 37. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 38. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 39. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 40. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 41. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 42. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 43. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 44. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 45. U.S. BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 46. U.S. BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 47. U.S. BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 48. U.S. BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 49. U.S. BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 50. CANADA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 51. CANADA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 52. CANADA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 53. CANADA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 54. CANADA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 55. UK BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 56. UK BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 57. UK BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 58. UK BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 59. UK BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 60. GERMANY BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 61. GERMANY BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 62. GERMANY BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 63. GERMANY BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 64. GERMANY BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 65. ROE BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 66. ROE BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 67. ROE BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 68. ROE BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 69. ROE BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 70. CHINA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 71. CHINA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 72. CHINA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 73. CHINA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 74. CHINA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 75. INDIA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 76. INDIA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 77. INDIA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 78. INDIA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 79. INDIA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 80. JAPAN BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 81. JAPAN BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 82. JAPAN BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 83. JAPAN BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 84. JAPAN BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 85. ROAPAC BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 86. ROAPAC BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 87. ROAPAC BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 88. ROAPAC BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 89. ROAPAC BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 90. BRAZIL BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 91. BRAZIL BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 92. BRAZIL BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 93. BRAZIL BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 94. BRAZIL BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 95. MEXICO BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 96. MEXICO BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 97. MEXICO BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 98. MEXICO BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 99. MEXICO BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 100. ROLA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 101. ROLA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 102. ROLA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 103. ROLA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 104. ROLA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 105. ROW BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 106. ROW BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 107. ROW BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 108. ROW BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 109. ROW BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

List of Figures

  • FIG 1. BIOMARKER MARKET, RESEARCH METHODOLOGY
  • FIG 2. BIOMARKER MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. BIOMARKER MARKET, KEY TRENDS 2016
  • FIG 5. BIOMARKER MARKET, GROWTH PROSPECTS 2017-2025
  • FIG 6. BIOMARKER MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. BIOMARKER MARKET, PEST ANALYSIS
  • FIG 8. BIOMARKER MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 10. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 11. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 12. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 13. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 14. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 15. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 16. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 17. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 18. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 19. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 20. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 21. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 22. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 23. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 24. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 25. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 26. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 27. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 28. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 29. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 30. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 31. BIOMARKER MARKET, REGIONAL SNAPSHOT 2015 & 2025
  • FIG 32. NORTH AMERICA BIOMARKER MARKETMARKET 2015 & 2025 (USD BILLON)
  • FIG 33. EUROPE BIOMARKER MARKETMARKET 2015 & 2025 (USD BILLON)
  • FIG 34. ASIA PACIFIC BIOMARKER MARKETMARKET 2015 & 2025 (USD BILLON)
  • FIG 35. LATIN AMERICA BIOMARKER MARKETMARKET 2015 & 2025 (USD BILLON)
  • FIG 36. BIOMARKER MARKET, COMPANY MARKET SHARE ANALYSIS (2016)
目次

Global Biomarker Market to reach USD XX billion by 2025.

Global Biomarker Market valued approximately USD 29.5 billion in 2017 is anticipated to grow with a healthy growth rate of more than 13% over the forecast period 2018-2025. The Biomarker Market is continuously growing in across the world over the upcoming years. Biomarker is a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures and biological procedures. It is also known as signature molecule or molecular marker. Increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries are the substantial driving factors of the market across the world. Furthermore, growing demand from emerging economies is creating numerous opportunity in the market over the upcoming years. Biomarkers are used to assist medical professionals to take effective clinical decisions and it also helps in diagnosing the health of patients. Also, biomarkers are predicting drug efficacy quickly than conventional clinical endpoints. These benefits of Biomarker also increasing demand among its end-user industries over the upcoming years. However, high capital investments and low cost-benefit ratio, poorly suited regulatory and reimbursement systems, and technical issues related to sample collection and storage is the restraining factors of the market across the globe.

The regional analysis of Global Biomarker Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region in the global Biomarker market due to growing prevalence of cancer and increasing adoption of precision medicine in the region. Europe is also estimated to grow in the global Biomarker market over the forecasted period 2018-2025. However, Asia-Pacific is also witnessed to grow at higher rate over the forecasted period 2018-2025.

The major market player included in this report are:

  • Abbott Laboratories
  • Medtronic
  • BG Medicine Inc.
  • Hoffmann LA Roche Ltd.
  • Siemens Healthnineers
  • Nexus-DX
  • Qiagen N.V.
  • Lifesign LLC

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Indication:

  • Cancer, Cardiovascular Disorder
  • Infectious Diseases
  • Neurological Disorder
  • Immunological Disorder
  • Others

By Application:

  • Diagnosis
  • Drug Discovery and Development
  • Others

By End-Use:

  • Hospitals
  • Research Laboratories
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories

By Product Type:

  • Biomarker Test Kits
  • Biomarker Analyzers

By Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2015, 2016

Base year - 2017

Forecast period - 2018 to 2025

Target Audience of the Global Biomarker Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

TABLE OF CONTENTS

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
    • 1.3.1. Biomarker Market, by Disease Indication, 2015-2025 (USD Billion)
    • 1.3.2. Biomarker Market, by Application, 2015-2025 (USD Billion)
    • 1.3.3. Biomarker Market, by End-Use, 2015-2025 (USD Billion)
    • 1.3.4. Biomarker Market, by Product Type, 2015-2025 (USD Billion)
    • 1.3.5. Biomarker Market, by Region, 2015-2025 (USD Billion)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Biomarker Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Biomarker Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Biomarker Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Value Chain Analysis
    • 4.3.1. Supplier
    • 4.3.2. Manufacturers/Service Provider
    • 4.3.3. Distributors
    • 4.3.4. End-Uses
  • 4.4. Key Buying Criteria
  • 4.5. Regulatory Framework
  • 4.6. Cost Structure Analysis
    • 4.6.1. Raw Material Cost Analysis
    • 4.6.2. Manufacturing Cost Analysis
    • 4.6.3. Labour Cost Analysis
  • 4.7. Investment Vs Adoption Scenario
  • 4.8. Analyst Recommendation & Conclusion

Chapter 5. Biomarker Market, by Disease Indication

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Key Market Players
  • 5.4. Biomarker Market, Sub Segment Analysis
    • 5.4.1. Cancer
      • 5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.2. Cardiovascular Disorder
      • 5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.3. Infectious Disease
      • 5.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.4. Neurological Disorder
      • 5.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.5. Immunological Disorder
      • 5.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.6. Others
      • 5.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Biomarker Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Key Market Players
  • 6.4. Biomarker Market, Sub Segment Analysis
    • 6.4.1. Diagnosis
      • 6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.4.2. Drug Discovery and Development
      • 6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.4.3. Others
      • 6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Biomarker Market, by End-Use

  • 7.1. Market Snapshot
  • 7.2. Market Performance - Potential Model
  • 7.3. Key Market Players
  • 7.4. Biomarker Market, Sub Segment Analysis
    • 7.4.1. Hospitals
      • 7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.2. Research Laboratories
      • 7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.3. Ambulatory Surgical Centers
      • 7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.4. Diagnostic Laboratories
      • 7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Biomarker Market, by Product Type

  • 8.1. Market Snapshot
  • 8.2. Market Performance - Potential Model
  • 8.3. Key Market Players
  • 8.4. Biomarker Market, Sub Segment Analysis
    • 8.4.1. Biomarker Test Kits
      • 8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 8.4.2. Biomarker Analyzers
      • 8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 9. Biomarker Market, by Regional Analysis

  • 9.1. Biomarker Market, Regional Market Snapshot (2015-2025)
  • 9.2. North America Biomarker Market Snapshot
    • 9.2.1. U.S.
      • 9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.2.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.2.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.2.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 9.2.2. Canada
      • 9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.2.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.2.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.2.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 9.3. Europe Biomarker Market Snapshot
    • 9.3.1. U.K.
      • 9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.1.6.
    • 9.3.2. Germany
      • 9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 9.3.3. France
      • 9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.3.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.3.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.3.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 9.3.4. Rest of Europe
      • 9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.4.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.4.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.4.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 9.4. Asia Biomarker Market Snapshot
    • 9.4.1. China
      • 9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 9.4.2. India
      • 9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 9.4.3. Japan
      • 9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.3.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.3.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.3.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 9.4.4. Rest of Asia Pacific
      • 9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.4.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.4.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.4.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 9.5. Latin America Biomarker Market Snapshot
    • 9.5.1. Brazil
      • 9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.5.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.5.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.5.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 9.5.2. Mexico
      • 9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.5.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.5.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.5.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 9.6. Rest of The World
    • 9.6.1. South America
      • 9.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.6.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.6.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.6.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.6.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 9.6.2. Middle East and Africa
      • 9.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.6.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.6.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.6.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.6.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 10. Competitive Intelligence

  • 10.1. Company Market Share (Subject to Data Availability)
  • 10.2. Top Market Strategies
  • 10.3. Company Profiles
    • 10.3.1. Abbott Laboratories
      • 10.3.1.1. Overview
      • 10.3.1.2. Financial (Subject to Data Availability)
      • 10.3.1.3. Summary
      • 10.3.1.4. Recent Developments
    • 10.3.2. Medtronic
    • 10.3.3. BG Medicine Inc.
    • 10.3.4. Hoffmann LA Roche Ltd.
    • 10.3.5. Siemens Healthnineers
    • 10.3.6. Nexus-DX
    • 10.3.7. Qiagen N.V.
    • 10.3.8. Lifesign LLC

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
    • 11.1.6. Research Assumption
Back to Top